AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
US9585920B2
(en)
|
2011-02-04 |
2017-03-07 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
US9457077B2
(en)
|
2009-11-18 |
2016-10-04 |
Katherine Rose Kovarik |
Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
|
HRP20220751T1
(hr)
|
2010-02-01 |
2022-09-02 |
Rebiotix, Inc. |
Bakterioterapija clostridium difficile kolitisa
|
EP2536849B1
(en)
|
2010-02-17 |
2016-05-11 |
Gen-Probe Incorporated |
Compositions and methods to detect atopobium vaginae nucleic acid
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
EP3311825A1
(en)
|
2010-08-04 |
2018-04-25 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them
|
US10314865B2
(en)
|
2011-02-04 |
2019-06-11 |
Katherine Rose Kovarik |
Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
US10085938B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for preventing sore throat in humans
|
US10835560B2
(en)
|
2013-12-20 |
2020-11-17 |
Joseph E. Kovarik |
Reducing the likelihood of skin cancer in an individual human being
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
US9987224B2
(en)
|
2011-02-04 |
2018-06-05 |
Joseph E. Kovarik |
Method and system for preventing migraine headaches, cluster headaches and dizziness
|
US11357722B2
(en)
|
2011-02-04 |
2022-06-14 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US10111913B2
(en)
|
2011-02-04 |
2018-10-30 |
Joseph E. Kovarik |
Method of reducing the likelihood of skin cancer in an individual human being
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
US10010568B2
(en)
|
2011-02-04 |
2018-07-03 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a spirochetes infection in a human being
|
US10687975B2
(en)
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
US9730967B2
(en)
|
2011-02-04 |
2017-08-15 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
US10548761B2
(en)
|
2011-02-04 |
2020-02-04 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
US10086018B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
PL2683390T3
(pl)
|
2011-03-09 |
2018-04-30 |
Regents Of The University Of Minnesota |
Kompozycje i sposoby przeszczepiania mikrobioty okrężnicy
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
CA2892588A1
(en)
|
2011-12-01 |
2013-06-06 |
School Corporation, Azabu Veterinary Medicine Educational Institution |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
WO2013130773A2
(en)
|
2012-02-29 |
2013-09-06 |
Ethicon Endo-Surgery, Inc. |
Compositions of microbiota and methods related thereto
|
EP3360560A1
(en)
*
|
2012-03-17 |
2018-08-15 |
The Regents of the University of California |
Composition for treating acne
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
WO2013148258A1
(en)
|
2012-03-29 |
2013-10-03 |
Jerome Schentag |
Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
US10220089B2
(en)
|
2012-08-29 |
2019-03-05 |
California Institute Of Technology |
Diagnosis and treatment of autism spectrum disorder
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
AU2014212003C1
(en)
|
2013-02-04 |
2020-07-16 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
AU2014239883B2
(en)
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
US20160286801A1
(en)
|
2013-03-15 |
2016-10-06 |
Suncor Energy Inc. |
Herbicidal Compositions
|
AU2014232370B2
(en)
*
|
2013-03-15 |
2018-11-01 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
CA2914636C
(en)
|
2013-06-05 |
2021-04-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
JP6637885B2
(ja)
|
2013-07-21 |
2020-01-29 |
ペンデュラム セラピューティクス, インコーポレイテッド |
マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
|
RU2722482C2
(ru)
|
2013-11-25 |
2020-06-01 |
Серес Терапеутикс, Инк. |
Синергические бактериальные композиции и способы их получения и применения
|
WO2015095241A2
(en)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
CA2941694A1
(en)
*
|
2014-03-06 |
2015-09-11 |
Research Institute At Nationwide Children's Hospital |
Probiotic formulations and methods for use
|
US10624934B2
(en)
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
US9783858B2
(en)
*
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
US10766799B2
(en)
|
2014-05-23 |
2020-09-08 |
Nch Corporation |
Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
|
FI127671B
(en)
|
2014-05-28 |
2018-11-30 |
Filip Scheperjans |
Procedure for the diagnosis of Parkinson's disease
|
US20160016002A1
(en)
*
|
2014-07-17 |
2016-01-21 |
John Todd Kuenstner |
Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Probiotics
|
CA2954087C
(en)
*
|
2014-07-25 |
2023-09-19 |
Biosynth S.R.L. |
Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
|
US20170223968A1
(en)
|
2014-08-04 |
2017-08-10 |
Basf Se |
Antifungal paenibacillus strains, fusaricidin-type compounds, and their use
|
US10900043B2
(en)
|
2014-09-02 |
2021-01-26 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for treating bacterial disease
|
WO2016036839A1
(en)
*
|
2014-09-02 |
2016-03-10 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for treating gonorrhea
|
US10335390B2
(en)
|
2014-09-05 |
2019-07-02 |
Symbiomix Therapeutics, Llc |
Secnidazole for use in the treatment of bacterial vaginosis
|
WO2016057671A1
(en)
*
|
2014-10-07 |
2016-04-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
US9760676B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
|
US10265009B2
(en)
|
2014-10-21 |
2019-04-23 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
|
US9703929B2
(en)
|
2014-10-21 |
2017-07-11 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics
|
US9758839B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
|
US10357157B2
(en)
|
2014-10-21 |
2019-07-23 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
|
US10793907B2
(en)
|
2014-10-21 |
2020-10-06 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
|
US9754080B2
(en)
|
2014-10-21 |
2017-09-05 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions
|
US10073952B2
(en)
|
2014-10-21 |
2018-09-11 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
|
US10409955B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions
|
US10169541B2
(en)
|
2014-10-21 |
2019-01-01 |
uBiome, Inc. |
Method and systems for characterizing skin related conditions
|
US10311973B2
(en)
|
2014-10-21 |
2019-06-04 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
|
US10325685B2
(en)
|
2014-10-21 |
2019-06-18 |
uBiome, Inc. |
Method and system for characterizing diet-related conditions
|
US10410749B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
|
US9710606B2
(en)
|
2014-10-21 |
2017-07-18 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
US10395777B2
(en)
|
2014-10-21 |
2019-08-27 |
uBiome, Inc. |
Method and system for characterizing microorganism-associated sleep-related conditions
|
US10346592B2
(en)
|
2014-10-21 |
2019-07-09 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
US10777320B2
(en)
|
2014-10-21 |
2020-09-15 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
|
EP3212289A4
(en)
|
2014-10-30 |
2018-05-16 |
California Institute of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
EP3998074A1
(en)
|
2014-10-30 |
2022-05-18 |
California Institute of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
EP3212001A4
(en)
|
2014-10-31 |
2018-04-25 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
WO2016086161A1
(en)
*
|
2014-11-25 |
2016-06-02 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and gvhd
|
MA41020A
(fr)
*
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
EP3193901B1
(en)
|
2014-12-23 |
2018-04-04 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
EP3065748B1
(en)
|
2014-12-23 |
2017-11-22 |
4D Pharma Research Limited |
A bacteroides thetaiotaomicron strain and its use in reducing inflammation
|
WO2016105498A1
(en)
|
2014-12-23 |
2016-06-30 |
Synthetic Biologics, Inc. |
Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
|
WO2016103005A1
(en)
|
2014-12-23 |
2016-06-30 |
Institut Pasteur |
Method of culturing segmented filamentous bacteria in vitro
|
EP3253396A4
(en)
*
|
2015-02-06 |
2018-08-29 |
Western University Of Health Sciences |
Probiotic compositions and methods of use
|
WO2016144856A1
(en)
|
2015-03-06 |
2016-09-15 |
Synthetic Biologics, Inc. |
Safe and effective beta-lactamase dosing for microbiome protection
|
EP3268018A4
(en)
*
|
2015-03-12 |
2018-10-31 |
The University of British Columbia |
Bacterial compositions and methods of use thereof
|
WO2016147121A1
(en)
*
|
2015-03-16 |
2016-09-22 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Archaebacteria in bioactive animal feed, method of making the composition and methods employing the composition
|
CN107849564A
(zh)
|
2015-04-03 |
2018-03-27 |
奎斯特诊断投资股份有限公司 |
用于检测致病性钩端螺旋体菌株的测定
|
AU2016250102A1
(en)
*
|
2015-04-13 |
2017-11-09 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
|
US10246753B2
(en)
|
2015-04-13 |
2019-04-02 |
uBiome, Inc. |
Method and system for characterizing mouth-associated conditions
|
AU2016250104B2
(en)
*
|
2015-04-13 |
2022-02-10 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
|
CN107835692B
(zh)
*
|
2015-04-13 |
2022-08-02 |
普梭梅根公司 |
用于皮肤系统状况的微生物组来源的表征、诊断和治疗的方法及系统
|
EP3283087A4
(en)
*
|
2015-04-14 |
2019-03-13 |
Ubiome Inc. |
METHOD AND SYSTEM FOR MICROBIOMEDIVED DIAGNOSTICS AND THERAPEUTICS FOR DISEASES OF THE ENDOCRINE SYSTEM
|
FR3035328B1
(fr)
|
2015-04-24 |
2019-08-23 |
Maat Pharma |
Procede de preparation d'un echantillon de microbiote fecal
|
FR3035317B1
(fr)
|
2015-04-24 |
2019-06-14 |
Maat Pharma |
Dispositif de prelevement de micro-organismes, kit de prelevement comprenant un tel dispositif et procede de prelevement mettant en œuvre un tel dispositif
|
WO2016183577A1
(en)
*
|
2015-05-14 |
2016-11-17 |
Crestovo Llc |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
CA2986485A1
(en)
|
2015-05-22 |
2016-12-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
WO2016196653A1
(en)
|
2015-06-01 |
2016-12-08 |
Symbiomix Therapeutics, Llc |
Novel nitroimidazole formulations and uses thereof
|
CN105067731B
(zh)
*
|
2015-06-05 |
2017-06-16 |
中国农业科学院兰州兽医研究所 |
一种弓形虫感染后血清中生物标记物的筛选方法及筛选出的生物标记物的应用
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
IL281424B2
(en)
*
|
2015-06-09 |
2023-10-01 |
Rebiotix Inc |
Microbiota restoration treatment preparations and production methods
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
EA038405B1
(ru)
|
2015-06-15 |
2021-08-24 |
4Д Фарма Рисёрч Лимитед |
ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ШТАММЫ БАКТЕРИИ Bifidobacterium breve, ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПАТОЛОГИЧЕСКОГО СОСТОЯНИЯ, ОПОСРЕДОВАННОГО IL-17 ИЛИ Th17
|
MA41010B1
(fr)
*
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
AU2016278067B2
(en)
|
2015-06-15 |
2022-09-22 |
Cj Bioscience, Inc. |
Compositions comprising bacterial strains
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
SI3307288T1
(sl)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Spojine, ki vsebujejo bakterijske seve
|
US10632157B2
(en)
|
2016-04-15 |
2020-04-28 |
Ascus Biosciences, Inc. |
Microbial compositions and methods of use for improving fowl production
|
US9938558B2
(en)
|
2015-06-25 |
2018-04-10 |
Ascus Biosciences, Inc. |
Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
EP3314007B1
(en)
|
2015-06-25 |
2024-01-24 |
Native Microbials, Inc. |
Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
US10851399B2
(en)
|
2015-06-25 |
2020-12-01 |
Native Microbials, Inc. |
Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
CN108348558A
(zh)
*
|
2015-07-08 |
2018-07-31 |
赛里斯治疗公司 |
治疗结肠炎的方法
|
EP3341000A4
(en)
*
|
2015-08-24 |
2019-02-20 |
Nubyiota LLC |
SYSTEMS AND METHODS FOR THE TREATMENT OF DYSBIOSIS USING BACTERIAL POPULATIONS DERIVED FROM FECES
|
JP2018531908A
(ja)
|
2015-09-04 |
2018-11-01 |
メモリアル スローン ケタリング キャンサー センター |
癌の再発のリスクを検出するための方法及び組成物
|
AU2016321333A1
(en)
*
|
2015-09-09 |
2018-04-26 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health
|
US20190216861A1
(en)
*
|
2015-09-22 |
2019-07-18 |
Mayo Foundation For Medical Education And Research |
Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection
|
BR112018005863B1
(pt)
|
2015-09-24 |
2024-02-27 |
Agriculture Victoria Services Pty Ltd |
Método para isolamento, seleção e/ou caracterização de uma linhagem endofítica
|
EP3355893A4
(en)
|
2015-09-29 |
2019-06-12 |
Kimberly-Clark Worldwide, Inc. |
SYNERGISTIC COMPOSITION FOR MAINTAINING A HEALTHY BALANCE OF THE MICROFLORE
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
KR20180093903A
(ko)
|
2015-11-03 |
2018-08-22 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
음식 알레르기의 치료 및/또는 예방을 위한 치료용 미생물총
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
MD3209310T2
(ro)
|
2015-11-20 |
2018-06-30 |
4D Pharma Res Ltd |
Compoziții care conțin tulpini bacteriene
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
KR20180083894A
(ko)
*
|
2015-11-24 |
2018-07-23 |
세레스 테라퓨틱스, 인코포레이티드 |
설계된 박테리아 조성물
|
US10568916B2
(en)
|
2015-11-30 |
2020-02-25 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
US10675347B2
(en)
|
2015-11-30 |
2020-06-09 |
Joseph E. Kovarik |
Method and system for protecting honey bees from fipronil pesticides
|
US10086024B2
(en)
|
2015-11-30 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
US11529412B2
(en)
|
2015-11-30 |
2022-12-20 |
Seed Health, Inc. |
Method and system for protecting honey bees from pesticides
|
US10933128B2
(en)
|
2015-11-30 |
2021-03-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees from pesticides
|
WO2017100420A1
(en)
*
|
2015-12-08 |
2017-06-15 |
Mayo Foundation For Medical Education And Research |
Biomarkers for predicting clostridium difficile infection treatment outcome
|
FR3045383B1
(fr)
|
2015-12-18 |
2019-06-14 |
Maat Pharma |
Procede de lyophilisation d'un echantillon de microbiote fecal
|
RU2018128578A
(ru)
|
2016-01-07 |
2020-02-10 |
Аскус Байосайенсиз, Инк. |
Способы улучшения продукции молока путем введения микробных консорциумов
|
CN106974940B
(zh)
*
|
2016-01-15 |
2020-08-25 |
深圳华大生命科学研究院 |
厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
|
IL243707A0
(en)
|
2016-01-20 |
2016-05-01 |
Galmed Res And Dev Ltd |
Treatment to regulate the microbiota in the intestine
|
LT3411052T
(lt)
|
2016-02-04 |
2021-01-11 |
Universiteit Gent |
Mikrobinių bendrijų naudojimas žmogaus ir gyvūno sveikatos pagerinimui
|
WO2017137834A1
(en)
*
|
2016-02-08 |
2017-08-17 |
University Of Oslo |
Bacterial growth media
|
EP3205209A1
(en)
|
2016-02-09 |
2017-08-16 |
Basf Se |
Mixtures and compositions comprising paenibacillus strains or metabolites thereof and other biopesticides
|
SI3313423T1
(sl)
|
2016-03-04 |
2019-07-31 |
4D Pharma Plc |
Sestavki, ki vsebujejo bakterijske seve Blautia za zdravljenje visceralne preobčutljivosti
|
EP3423093A4
(en)
|
2016-03-04 |
2019-11-13 |
The Regents of The University of California |
MICROBIAL CONSORTIUM AND USES THEREOF
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
AU2017234120A1
(en)
|
2016-03-14 |
2018-09-20 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
EP3432891A4
(en)
*
|
2016-03-24 |
2019-10-30 |
Paratek Pharmaceuticals, Inc. |
METHOD FOR THE TREATMENT AND PREVENTION OF C. DIFFICILE
|
KR102498391B1
(ko)
*
|
2016-04-05 |
2023-02-13 |
엔씨에이취 코오포레이션 |
영양소 풍부 발아 조성물 및 포자 배양 방법
|
US10897922B2
(en)
|
2016-04-05 |
2021-01-26 |
Nch Corporation |
Composition and method for germinative compounds in probiotic food and beverage products for human consumption
|
AU2017249595A1
(en)
*
|
2016-04-15 |
2018-11-08 |
Native Microbials, Inc. |
Methods for improving agricultural production of fowl by administration of microbial consortia or purified strains thereof
|
CA3021247A1
(en)
|
2016-04-19 |
2017-10-26 |
Genome Research Limited |
A therapeutic composition comprising at least one isolated bacterium from human stool samples and use thereof for treating dysbiosis
|
CN109715179A
(zh)
|
2016-04-21 |
2019-05-03 |
内科德生物群系公司 |
用于治疗皮肤病症的组合物和方法
|
US10252145B2
(en)
|
2016-05-02 |
2019-04-09 |
Bao Tran |
Smart device
|
JP2019523758A
(ja)
|
2016-05-23 |
2019-08-29 |
カリフォルニア インスティチュート オブ テクノロジー |
神経変性障害を治療するための腸内微生物叢の制御
|
US20170348360A1
(en)
*
|
2016-06-01 |
2017-12-07 |
Crestovo Llc |
Compositions and Methods for Treating Inflammatory Bowel Diseases (IBDs) and Other Disorders
|
ES2960053T3
(es)
*
|
2016-06-14 |
2024-02-29 |
Vedanta Biosciences Inc |
Tratamiento de infección por Clostridium difficile
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
WO2017218889A1
(en)
*
|
2016-06-16 |
2017-12-21 |
Ohio State Innovation Foundation |
Eubacterium probiotics and methods of treating or preventing heart disease
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
GB201703548D0
(en)
*
|
2017-03-06 |
2017-04-19 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN109475305B
(zh)
*
|
2016-07-13 |
2022-01-25 |
普梭梅根公司 |
用于微生物药物基因组学的方法和系统
|
GB201703552D0
(en)
*
|
2017-03-06 |
2017-04-19 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
TWI802545B
(zh)
*
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
KR101815692B1
(ko)
*
|
2016-07-25 |
2018-01-16 |
주식회사 고바이오랩 |
구강 세균의 군집을 이용한 대사성 질환 진단용 바이오 마커
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
WO2018031545A1
(en)
*
|
2016-08-11 |
2018-02-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for detecting oral squamous cell carcinomas
|
WO2018046485A1
(en)
|
2016-09-09 |
2018-03-15 |
Swecure Ab |
Use of butyricimonas and/or oxalobacter for treating irritable bowel syndrome
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
US11026978B2
(en)
|
2016-10-11 |
2021-06-08 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
JP6927512B2
(ja)
*
|
2016-10-26 |
2021-09-01 |
地方独立行政法人神奈川県立産業技術総合研究所 |
物体表面の抗菌性試験用菌液媒体
|
AU2017370681A1
(en)
*
|
2016-12-06 |
2019-06-27 |
Pendulum Therapeutics, Inc. |
Methods and compositions relating to isolated and purified microbes
|
GB201621123D0
(en)
*
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CA3048669A1
(en)
|
2016-12-15 |
2018-06-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
|
EP3554520A4
(en)
*
|
2016-12-16 |
2020-09-30 |
Vedanta Biosciences, Inc. |
METHODS AND COMPOSITIONS FOR DETERMINING BACTERIAL INTEGRITY
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
AU2017381697B2
(en)
*
|
2016-12-23 |
2020-12-24 |
Keio University |
Compositions and methods for the induction of CD8+ T-cells
|
CN110366596A
(zh)
|
2016-12-28 |
2019-10-22 |
埃斯库斯生物科技股份公司 |
用于对复杂异质群落中的完整微生物株系进行分析、确定其功能关系及相互作用以及基于此来识别和合成生物活性改性剂的方法、设备和系统
|
WO2018129249A1
(en)
*
|
2017-01-05 |
2018-07-12 |
The University Of Chicago |
Inhibition of enteric infection through the modulation of microbiota
|
CN107058490B
(zh)
*
|
2017-01-12 |
2018-03-06 |
杨俊杰 |
肠道及口腔菌群多样性及差异性的分析方法
|
US10381105B1
(en)
|
2017-01-24 |
2019-08-13 |
Bao |
Personalized beauty system
|
KR20190120235A
(ko)
*
|
2017-02-28 |
2019-10-23 |
킴벌리-클라크 월드와이드, 인크. |
미생물총의 건강한 균형을 유지하기 위한 상승적 조성물
|
US10052026B1
(en)
|
2017-03-06 |
2018-08-21 |
Bao Tran |
Smart mirror
|
CA3211208A1
(en)
|
2017-04-03 |
2018-10-11 |
Gusto Global, Llc |
Rational design of microbial-based biotherapeutics
|
CN110831606A
(zh)
|
2017-04-05 |
2020-02-21 |
克雷斯顿沃控股公司 |
治疗帕金森氏病(pd)和相关疾病的组合物和方法
|
US11040073B2
(en)
|
2017-04-05 |
2021-06-22 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
EP3388069B1
(en)
|
2017-04-12 |
2019-05-01 |
ETH Zurich |
Consortia of living bacteria useful for treatment of microbiome dysbiosis
|
US11044924B2
(en)
|
2017-04-28 |
2021-06-29 |
Native Microbials, Inc. |
Methods for supporting grain intensive and or energy intensive diets in ruminants by administration of a synthetic bioensemble of microbes or purified strains therefor
|
WO2018213204A1
(en)
|
2017-05-15 |
2018-11-22 |
Axial Biotherapeutics, Inc. |
Inhibitors of microbially induced amyloid
|
EP3630136B1
(en)
|
2017-05-22 |
2021-04-21 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2018218159A1
(en)
|
2017-05-26 |
2018-11-29 |
Crestovo Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
WO2018229188A1
(en)
|
2017-06-14 |
2018-12-20 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
IL292373A
(en)
|
2017-06-14 |
2022-06-01 |
4D Pharma Res Ltd |
Preparations containing bacterial strains of the Megasphere genus and their use
|
US20200268017A1
(en)
*
|
2017-06-20 |
2020-08-27 |
Cornell University |
Probiotic compositions and methods
|
EP3661525A4
(en)
*
|
2017-08-04 |
2020-07-22 |
Second Genome, Inc. |
ROSEBURIA HOMINIS, EUBACTERIUM ELIGENS AND COMBINATIONS THEREOF AS BIOTHERAPEUTICS
|
CN107854495B
(zh)
*
|
2017-08-04 |
2021-04-13 |
青岛东海药业有限公司 |
凝结芽孢杆菌在制备降低血尿酸制剂中的应用
|
EP3662087B1
(en)
*
|
2017-08-06 |
2022-10-05 |
Second Genome, Inc. |
Streptococcus australis as a biotherapeutics
|
CN111328284A
(zh)
|
2017-08-07 |
2020-06-23 |
芬奇治疗公司 |
用于维持和恢复健康的肠道屏障的组合物和方法
|
US20200360450A1
(en)
*
|
2017-08-07 |
2020-11-19 |
Finch Therapeutics, Inc. |
Treatment of liver disease by modulation of the microbiome
|
CN111295187A
(zh)
|
2017-08-14 |
2020-06-16 |
胺细拉健康公司 |
用于治疗肝脏疾病的氨基酸组合物
|
KR20200040277A
(ko)
|
2017-08-14 |
2020-04-17 |
세레스 테라퓨틱스, 인코포레이티드 |
담즙정체성 질환 치료를 위한 조성물 및 방법
|
TWI640314B
(zh)
*
|
2017-08-22 |
2018-11-11 |
長庚生物科技股份有限公司 |
戈氏副擬桿菌用於降低胰島素抗性及提升葡萄糖耐受性之用途
|
WO2019046401A1
(en)
*
|
2017-08-29 |
2019-03-07 |
Evelo Biosciences, Inc. |
TREATMENT OF CANCER USING BLAUTIA STRAIN
|
WO2019043051A1
(en)
|
2017-08-29 |
2019-03-07 |
Chr. Hansen A/S |
STABLE CAPSULES COMPRISING A FECAL MICROBIOTE OR A CULTURE OF MICROORGANISMS
|
CN111372596A
(zh)
|
2017-08-30 |
2020-07-03 |
潘德勒姆治疗公司 |
用于治疗微生物组相关病症的方法和组合物
|
EP3453395B1
(en)
|
2017-09-08 |
2023-10-18 |
Deutsches Rheuma-Forschungszentrum Berlin |
Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system
|
CN111132684A
(zh)
*
|
2017-09-26 |
2020-05-08 |
第二基因组股份有限公司 |
作为生物治疗药物的血孪生球菌
|
US11825862B2
(en)
|
2017-10-18 |
2023-11-28 |
Native Microbials, Inc. |
Fowl production by administration of a synthetic bioensemble of microbes or purified strains thereof
|
JP2021501185A
(ja)
|
2017-10-30 |
2021-01-14 |
セレス セラピューティクス インコーポレイテッド |
抗生物質耐性を処置するための組成物及び方法
|
FI128395B
(en)
|
2017-11-09 |
2020-04-30 |
Kemira Oyj |
Method for making a fibrous web
|
CN107653243B
(zh)
*
|
2017-11-15 |
2021-06-15 |
中国农业科学院农业基因组研究所 |
一种从肠道内容物中提取微生物宏基因组dna的方法
|
CN107828705A
(zh)
*
|
2017-12-31 |
2018-03-23 |
佛山市艳晖生物科技有限公司 |
一株解淀粉芽孢杆菌及其在防治孤独症上的应用
|
TWI813620B
(zh)
*
|
2018-02-02 |
2023-09-01 |
香港中文大學 |
糞便微生物群移植的糞便真菌微生物和治療功效
|
WO2019156234A1
(en)
*
|
2018-02-09 |
2019-08-15 |
Keio University |
Compositions and methods for the induction of cd8+ t-cells
|
CN110211629A
(zh)
*
|
2018-02-11 |
2019-09-06 |
中国科学院昆明动物研究所 |
一种评估微生物群落宏基因(或普通生物群落宏遗传)多样性和相似性的概念和方法
|
CN112118852A
(zh)
*
|
2018-03-29 |
2020-12-22 |
赛里斯治疗公司 |
用于治疗炎症性肠病的组合物和方法
|
AU2019253714A1
(en)
|
2018-04-10 |
2020-11-26 |
Siolta Therapeutics, Inc. |
Microbial consortia
|
WO2019200271A1
(en)
|
2018-04-13 |
2019-10-17 |
White Dog Labs, Inc. |
An improved method for selecting probiotics
|
KR102225939B1
(ko)
*
|
2018-04-19 |
2021-03-10 |
주식회사 고바이오랩 |
신규한 Bacteroides vulgatus 균주 및 이를 유효 성분으로 하는 면역 및 대사성 질환 예방 또는 치료용 조성물
|
US20210352889A1
(en)
*
|
2018-04-30 |
2021-11-18 |
Suncor Energy Inc. |
Macrocyclic tetrapyrrole compounds, compositions and methods for increasing abiotic stress resistance in plants
|
CN113151036A
(zh)
*
|
2018-05-11 |
2021-07-23 |
韩国亿诺生物有限公司 |
具有预防或治疗癌症的效果的新型菌株
|
CA3101242A1
(en)
*
|
2018-05-23 |
2019-11-28 |
Brigham Young University |
Bacteriophage compositions and kits and related methods
|
EP3801065A4
(en)
*
|
2018-05-24 |
2022-11-02 |
Seres Therapeutics, Inc. |
DESIGN OF BACTERIAL COMPOSITIONS AND THEIR USE
|
WO2019231712A1
(en)
*
|
2018-05-29 |
2019-12-05 |
Stc.Unm |
Virus-like particle compositions and methods of using same
|
EP3801578B1
(en)
*
|
2018-06-07 |
2023-08-30 |
Artugen Therapeutics Ltd. |
B. amyloliquefaciens strain and therapeutic use
|
EP3806874A1
(en)
*
|
2018-06-14 |
2021-04-21 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt) compositions and methods of manufacture
|
JP2021527639A
(ja)
*
|
2018-06-19 |
2021-10-14 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
生物療法製品を含む剤形
|
EP3810123A1
(en)
|
2018-06-20 |
2021-04-28 |
Axcella Health Inc. |
Compositions and methods for the treatment of fat infiltration in muscle
|
EP3594321A1
(en)
|
2018-07-10 |
2020-01-15 |
Université catholique de Louvain |
Dusodibacter, a novel bacterial genus of the gastroinstestinal microbiota and uses thereof
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
WO2020041581A1
(en)
*
|
2018-08-23 |
2020-02-27 |
Cornell University |
Methods and compositions for preventing and treating inflammatory bowel disease and nonalcoholic fatty liver disease
|
US11401500B2
(en)
|
2018-08-29 |
2022-08-02 |
Nch Corporation |
System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
|
KR20210065969A
(ko)
|
2018-09-27 |
2021-06-04 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
간질 및 관련 장애를 치료하기 위한 조성물 및 방법
|
CN109234195A
(zh)
*
|
2018-09-28 |
2019-01-18 |
邓州市汇海农业科技有限公司 |
一种稻田微生物复合菌剂
|
KR102135195B1
(ko)
*
|
2018-10-08 |
2020-07-17 |
아주대학교산학협력단 |
테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
|
JP2022504185A
(ja)
*
|
2018-10-09 |
2022-01-13 |
フォーディー ファーマ リサーチ リミテッド |
細菌株を含む組成物
|
CN113365645A
(zh)
*
|
2018-11-09 |
2021-09-07 |
布里格姆及妇女医院股份有限公司 |
用于治疗和/或预防生态失调的治疗性微生物群
|
CN113557027A
(zh)
*
|
2018-12-28 |
2021-10-26 |
普通益生菌股份有限公司 |
用于治疗胃肠道病原体的工程抗微生物益生菌的联合
|
WO2020166708A1
(ja)
*
|
2019-02-15 |
2020-08-20 |
コンビ株式会社 |
新規乳酸菌およびそれを含有する組成物
|
CN110195027B
(zh)
*
|
2019-03-08 |
2022-03-01 |
大连理工大学 |
烟草节杆菌zl-1及其堆肥低温发酵菌剂的制备方法与应用
|
CN114007694A
(zh)
*
|
2019-03-25 |
2022-02-01 |
以色列国家农业部、农村发展农业研究组织·沃尔卡尼机构 |
治疗牛乳腺炎的方法
|
WO2020198503A1
(en)
*
|
2019-03-26 |
2020-10-01 |
The Children's Medical Center Corporation |
Therapeutic microbiota for the treatment and/or prevention of dysbiosis
|
TW202108153A
(zh)
*
|
2019-05-10 |
2021-03-01 |
英商4D製藥研究有限公司 |
包含細菌菌株之組成物
|
CA3141664A1
(en)
*
|
2019-05-23 |
2020-11-26 |
American Molecular Laboratories, Inc. |
Methods for detecting a level of h. pylori in a fecal sample
|
EP3958690A4
(en)
*
|
2019-05-31 |
2023-04-19 |
South Dakota Board of Regents |
PROBIOTICS FOR INHIBITING ENTERIC PATHOGENS
|
EP3999029A4
(en)
*
|
2019-07-17 |
2023-07-26 |
University of Utah Research Foundation |
CLOSTRIDIA CONSORTIUM COMPOSITIONS AND METHODS FOR TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL SYNDROME
|
BR112022000875A2
(pt)
*
|
2019-07-19 |
2022-03-29 |
Finch Therapeutics Holdings Llc |
Métodos e produtos para tratamento de distúrbios gastrointestinais
|
US20220287995A1
(en)
*
|
2019-07-30 |
2022-09-15 |
The Regents Of The University Of California |
Compositions and methods for inhibiting bacterial virulence and flim-based device and method for antibiotic susceptibility testing
|
CN110358849A
(zh)
*
|
2019-07-30 |
2019-10-22 |
中国医学科学院北京协和医院 |
源于肠道的诊断胰腺炎的生物标志物、筛选方法及其用途
|
CN112438995A
(zh)
|
2019-09-04 |
2021-03-05 |
台达电子工业股份有限公司 |
抑制具万古霉素抗药性肠球菌的益生菌及其组合与其用途
|
JP2022551201A
(ja)
|
2019-10-07 |
2022-12-07 |
シオルタ・セラピューティクス,インコーポレイテッド |
治療用医薬組成物
|
WO2021091981A1
(en)
*
|
2019-11-04 |
2021-05-14 |
Vedanta Biosciences, Inc. |
Compositions and methods for enhancing immune checkpoint inhibitor therapy
|
CA3159711A1
(en)
*
|
2019-11-27 |
2021-06-03 |
Asuncion Martinez |
Designed bacterial compositions and uses thereof
|
KR102215592B1
(ko)
*
|
2019-12-11 |
2021-02-15 |
주식회사 에이치이엠 |
신규한 락토바실러스 퍼멘텀 hem 1036 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
|
CN114760976A
(zh)
|
2019-12-16 |
2022-07-15 |
高露洁-棕榄公司 |
含有菊粉的口腔护理组合物
|
WO2021159068A1
(en)
|
2020-02-06 |
2021-08-12 |
Nch Corportion |
Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
|
EP4102984A1
(en)
*
|
2020-02-10 |
2022-12-21 |
Native Microbials, Inc. |
Microbial compositions and methods of use for canine enteropathy and dysbiosis
|
EP4106779A4
(en)
*
|
2020-02-18 |
2024-03-20 |
Memorial Sloan Kettering Cancer Center |
METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS WHO MAY BE AT RISK OF POOR CANCER SURVIVAL
|
US20230112887A1
(en)
*
|
2020-02-28 |
2023-04-13 |
Emory University |
Pentagalloyl Glucose Derived from Schinus Plants and Methods of Use
|
WO2021221110A1
(ja)
*
|
2020-04-29 |
2021-11-04 |
学校法人慶應義塾 |
Th1細胞及び/又はTh17細胞の増殖又は活性化を誘導する小腸内細菌
|
GB202007452D0
(en)
*
|
2020-05-19 |
2020-07-01 |
Microbiotica Ltd |
Threrapeutic bacterial composition
|
NL2025863B1
(en)
|
2020-06-19 |
2022-02-17 |
Acad Medisch Ct |
Fecal matter for treatment of cachexia
|
KR20230088680A
(ko)
|
2020-08-14 |
2023-06-20 |
프롤랙타 바이오사이언스, 인코포레이티드 |
박테리아 요법에 사용하기 위한 인간 모유 올리고당 조성물
|
EP4210504A1
(en)
*
|
2020-09-11 |
2023-07-19 |
MarvelBiome, Inc. |
Methods and uses of microbiome compositions
|
KR102470808B1
(ko)
*
|
2020-11-02 |
2022-11-28 |
주식회사 바이오미 |
염증성 장질환 예방 또는 치료용 조성물
|
CN116709924A
(zh)
*
|
2020-11-25 |
2023-09-05 |
赛里斯治疗公司 |
用于治疗移植物抗宿主病的设计的细菌组合物
|
US20240127925A1
(en)
*
|
2021-02-03 |
2024-04-18 |
Tata Consultancy Services Limited |
Method and system for designing personalized therapeutics and diet based on functions of microbiome
|
CN114948986A
(zh)
*
|
2021-02-19 |
2022-08-30 |
星聚樊生物科技有限公司 |
中草药多醣及其细菌组成物改善疾病的用途
|
KR102373888B1
(ko)
*
|
2021-03-26 |
2022-03-15 |
주식회사 에이치이엠파마 |
머신러닝 모델을 이용하여 변비 유무를 판별하는 방법 및 진단장치
|
KR102373886B1
(ko)
*
|
2021-03-26 |
2022-03-15 |
주식회사 에이치이엠파마 |
머신러닝 모델을 이용하여 장염 유무를 판별하는 방법 및 진단 장치
|
CN113106042A
(zh)
*
|
2021-05-20 |
2021-07-13 |
广西壮族自治区兽医研究所 |
预防鸽形目念珠菌病的微生物菌剂、制剂及其制备方法和应用
|
NL2028324B1
(en)
|
2021-05-28 |
2022-12-12 |
Caelus Pharmaceuticals B V |
Insulin-sensitizing agent and butyrate-producing bacterium
|
KR102583365B1
(ko)
*
|
2021-08-11 |
2023-09-27 |
코스맥스 주식회사 |
마이크로코커스 안타르크티쿠스 균주 및 그의 피부 상태 개선 용도
|
WO2023086883A1
(en)
*
|
2021-11-11 |
2023-05-19 |
Concerto Biosciences, Inc. |
Microbial compositions for the treatment of skin diseases
|
EP4183403A1
(en)
*
|
2021-11-19 |
2023-05-24 |
Lietuvos Sveikatos Mokslu Universitetas |
Modification of fecal microbiota with capsules containing gram-positive bacteria
|
WO2023132628A1
(ko)
*
|
2022-01-04 |
2023-07-13 |
주식회사 바이오뱅크힐링 |
신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
KR102438867B1
(ko)
*
|
2022-03-11 |
2022-09-02 |
주식회사 바이오뱅크힐링 |
코프로코커스 캐터스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
CN114317368B
(zh)
*
|
2022-01-05 |
2022-09-09 |
中国水产科学研究院南海水产研究所 |
一种利用盐渍四生球菌改善快速发酵鱼露风味的方法
|
WO2023161315A1
(en)
*
|
2022-02-23 |
2023-08-31 |
Société des Produits Nestlé S.A. |
Compositions and methods for reducing the occurrence of diarrhea by promoting blautia obeum in the gut microbiota
|
WO2023212492A2
(en)
*
|
2022-04-26 |
2023-11-02 |
Cedars-Sinai Medical Center |
Methanogens and prevotella as microbial convener for the treatment of diseases and diagnosis thereof
|
CN114965764A
(zh)
*
|
2022-05-18 |
2022-08-30 |
陕西安宁云生生物技术有限公司 |
便秘的诊断和治疗
|
CN115466690A
(zh)
*
|
2022-05-19 |
2022-12-13 |
同济大学 |
一种地芽孢杆菌新菌种及其培养方法和应用
|
CN116790402A
(zh)
*
|
2023-01-14 |
2023-09-22 |
西北农林科技大学 |
一株具有抗炎特性的单形拟杆菌菌株、培养方法及应用
|